Price movement over the last 24 hours
ARK Genomic Revolution ETF vs VanEck JP Morgan EM Local Currency Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while VanEck JP Morgan EM Local Currency Bond ETF trades at $25.55. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | EMLC | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $43.57 | $26.59 |
52-Week Low | $23.09 | $24.83 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EMLC trades at $25.55, up 0.43% on the day, with a bearish technical signal driven by moving averages. The ETF offers a trailing yield near 6.1%, supported by consistent monthly dividends, but lacks disclosed financial ratios. Recent news highlights institutional demand for emerging market bonds amid shifting Fed policy and geopolitical risks.
The outlook is mixed: high yield attracts income investors, but currency risk and capital erosion concerns persist. Short interest has surged 73%, reflecting skepticism. Key catalysts include Fed rate decisions and emerging market volatility, presenting opportunity for yield-seeking investors with high risk tolerance.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →